Pharma Journalist

Marketing and Customer Innovation Europe
2019-10-15 - 2019-10-16 | Novotel West London One Shortlands, London, W6 8DR, United Kingdom
We’re at a crossroads. On the one hand, pharma marketeers must adopt and master an array of technological innovations to transform customer relationships and better meet rising expectations.
On the other, successful innovation is currently inhibited by our failure to master the basics – with inconsistent multichannel interaction and a low cultural acceptance of non-traditional methods, whether it’s digital or education-led initiatives.
Let’s build the capability to create new collaborations and partnerships, both internally and externally, to strengthen what’s possible yet at the same time deliver on the fundamentals of customer-value. It’s no longer a nice-to-have – we must do this or face rapid extinction.
eyeforpharma Marketing and Customer Innovation Europe will bring together 250+ Marketing, Digital, CX, IT/CRM and Business Partnership/Technology pharma executives to bridge internal divides, share the industry pushing case studies and build market-leading customer experiences.
Attend and gain unique insights on:

Collaborate or die.
Break internal silos in commercial and medical affairs, partner with healthcare’s key innovators and decision makers, and bring the brightest FMCG knowledge and leadership inside
You’re brand obsessed!
Create true customer partnerships and influence behaviours with an above-brand, education-led approach
Digital transformation needs a cultural revolution.
Demonstrate the value of digital initiatives to ensure adoption across affiliates and departments
Harness big data.
Personalise customer interactions with an internal infrastructure built to comprehend and connect insights
Achieve customer-centricity.
Ensure new channel innovations and digital investments remain purpose-led to meet customer needs
Real-life technological innovation.
Channel your investments and cut through unnecessary hyperbole with current applications of technology breakthroughs

4 Reasons to Attend:
Case Studies: Practical, tangible advice and actions from your peers which you can put into practise in your own company
Out of Industry Speakers: Hear from some of the biggest leader in marketing out of the pharma industry sharing their top tips
Team Benefits: Group rates are now available for 2+ attendees, to ensure all interested peers can take advantage of this learning opportunity
All Stakeholders in One Room: Working together to ensure we are engaging in solution focused exchanges across all departments
Book before 19th July to save €300

SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
2019-10-15 - 2019-10-16 | Holiday Inn Kesington Forum, London, UK, London, United Kingdom
SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK.

The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.
This is due to the arising interest for pharmaceutical companies, primarily for the underlying benefits, including the potential discovery of mechanisms for more common diseases, and the involvement of many smaller biotechnology start-up companies who are more focused on rare diseases.
The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerative orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.
BENEFITS OF ATTENDING

HEAR about the success of orphan drug launches following the heavy involvement of patient advocacy programs
DISCUSS the potential changes in assessing the development of medicines across Europe
EXPLORE the future landscape orphan drugs following the market access and reimbursement challenges providers are currently facing.

PLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP
Thursday 17th October 2019
A deep dive into strategies for accelerating patient access of orphan drugs
Workshop Leader: Workshop Leaders: Solange Corriol-Rohou, Senior Director Regulatory Affairs & Policy Europe, AstraZeneca
Cecile Ollivier, Chief Operating Officer, Aparito
WHO SHOULD ATTEND?
CEOs, CSOs, Vice Presidents, Directors, Heads, Principals working in:

Medical Affairs
Medical Advisory
Clinical Operations
Rare Disease Research
Patient Advocacy
Commercial Officer
Orphan Drug Therapeutics
Healthcare
Regulatory Affairs
Rare Disease Charity Officers

For more details and to register or this event, visit the website at http://www.orphandrugs.co.uk/PJWL
EARLY BIRD-RATES

BOOK BY 31ST MAY AND SAVE £400
BOOK BY 28TH JUNE AND SAVE £300
BOOK BY 30TH AUGUST AND SAVE £200

Flow Cytometry Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Flow Cytometry is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Liquid Biopsies Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Liquid Biopsies Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

TMB & Neoantigen Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The TMB & Neoantigen Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Adoptive Cell Transfer Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Adoptive Cell Transfer Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Novel Antibody Therapeutics Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Novel Antibody Therapeutics Congress one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Pharmaceutical Cleanroom Technology Europe Conference
2019-10-09 - 2019-10-10 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s Pharmaceutical Cleanroom Technology Europe Conference
Conference: Wednesday 9 and Thursday 10 October 2019
Workshop: Tuesday 8 October 2019
Location: Copthorne Tara Hotel, London, UK
www.cleanroomtechnology.co.uk/pjwl
Sponsored by: Contec and Dupont
CHAIRMAN: James Drinkwater, Chairman, Pharmaceutical & Healthcare Science Society
Addressing the Microbiological Aspects in Cleanroom Design and Engineering
SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, taking place on the 9th and 10th October 2019 in London, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.

This one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals, biologicals, and cleanroom industry experts to explore hot topics within cleanroom design and engineering, best practices and regulation, environmental and contamination control, and pharmaceutical microbiology.
In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. Stringent regulatory standards for product approvals, technological advancements in cleanrooms, initiatives taken by private organisations to create awareness regarding cleanroom and growth of the healthcare sector globally are among the few factors expected to drive the market.
Compliance with the standards for product approvals is crucial and as a result manufacturing companies in various industries are dependent on cleanroom technology.
BENEFITS OF ATTENDING

EXPLORE the characteristics and relevance of air flow to better advise cleanroom design, engineering and manage contamination
DISCUSS the most current approaches to minimised cost and improved energy efficiency without compromising product quality
EXAMINE the latest contamination control strategies from leaders in the pharmaceutical industry
GAIN insight into cleaning and disinfection protocols from a risk-management approach

PLUS AN INTERACTIVE HALF DAY PRE-CONFERENCE WORKSHOP
Tuesday 8th October 2019, Copthorne Tara Hotel, London, UK
Environmental Classification, Qualification and Monitoring of GMP Controlled areas referencing ISO 14644-1 and risk based GMP
Workshop Leader: James Drinkwater, Chairman, Pharmaceutical and Healthcare Science Society
WHO SHOULD ATTEND?
Senior Micro Manager, QC Manager, Quality Director, Clean Room Design Managers, Design, Qualify and Testing – Clean Room (across the board), Head of Clean Room Technologies, Head of Compounding Pharmacies, Head of Clinical Drug Products, Head of Clinical Medical Device
Global Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK, Europe and USA.
EARLY BIRD-RATES

BOOK BY 31ST MAY AND SAVE £400
BOOK BY 28TH JUNE AND SAVE £300
BOOK BY 30th AUGUST AND SAVE £200

4th European Prefilled Syringes Summit
2019-10-09 - 2019-10-10 | Berlin, Germany
After the three successful ACI’s European Prefilled Syringes Summit, we are pleased to inform you that the 4th edition will take place this month on the 9th & 10th October in Berlin, Germany.

The two day event will explore the advancements in regulatory guidelines including Article 117 and what this will mean for interactions with notified bodies. The conference will highlight technical advancements in product design and usage, looking at the move towards autoinjectors. Our expert speakers will compare the use of glass syringes with plastic syringes, focus on how to minimise the impact of extractables and leachables, and address CCI regulations. Through in-depth presentations and interactive panel discussions, the conference will shed light onto how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes.
Key Topics Include:

Medical Device Regulations overview and updates
Technical advancements in product design and usage
Suitability of primary packaging components
Extractables and leachables
Manufacturing and supply barriers
Improving adherence through device innovation and human factors
Creating value with connectivity
Developments in biologics
Shifting to a pay-per-outcome market

For more information & 15% subscribers discounted registration, contact Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net
Join us in Berlin to exchange your point of view with your peers and engage in excellent networking opportunities.

Blockchain for Health Supply Chain
2019-10-08 - 2019-10-09 | The Westin Boston Waterfront, 425 Summer St, Boston, MA, 02210, United States
Blockchain for Health Supply Chain: Real-World Application is the definitive event for all key stakeholders across the supply chain to forge a path for collaboration and adoption of this transformative technology. Consortium and tech-agnostic, this conference provides a neutral platform for cross-community sharing of PoCs and discussion about the common challenges facing all blockchain implementation projects.

In its 2nd year, this event will continue to tackle the deep and difficult challenges associated with blockchain implementation – providing essential guidance for active adopters as well as those preparing to embark on their blockchain journey. Our mission is to help you get beyond PoC – and to get blockchain out of the lab and into business.
Find out more – get free event brochure here: https://ter.li/p0t4xu
Contact
(+1) 617 455 4188
info@hansonwade.com

19th Pharmacovigilance 2019
2019-10-08 - 2019-10-10 | Double Tree Suites by Hilton Hotel – 400 Soldiers Field Road, Boston, MA 02134
19th Pharmacovigilance 2019
“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”
08th – 10th October 2019, Hotel TBC, Cambridge, Boston, USA
19th Pharmacovigilance 2019 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. Hence, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting Pv development.
SPONSORS:

GOLD SPONSOR: Brookwood, AB Cube, AWINSA Life Sciences
BRONZE SPONSOR: 4C Pharma Solutions

KEY SPEAKERS:

DEREK ROY, Resident Agent in Charge, FDA
BRUNO MENDEZ, VP Global Quality Head Pharmacovigilance, Sanofi
MARIETTE BOERSTOEL-STREEFLAND, VP PharmacoVigilance & Drug Safety, Alexion Pharmaceuticals
TEGINDER SINGH, Senior Director Global Regulatory Affairs, Johnson & Johnson
COLLEEN WALSH, Senior Director, Pharmacovigilance & Regulatory Quality Management Operations, Alexion Pharmaceuticals
GERSON PELTZ, Senior Director – Oncology Safety Risk Lead, Pfizer
BRUCE DONZANTI, Senior Group Director, Regulatory Pharmacovigilance Policy, Genentech
WILLIAM WANG, Executive Director, Clinical Safety Statistics, Merck
MELVIN MUNSAKA, Senior Director, Head Safety Statistics, Abbvie
XIAO NI, Director, Scientific Computing and Consulting, Novartis
SHARON REID, Director, Risk Management Product Lead, Pfizer
HARISHA KADALI, Associate Medical Director, Takeda Pharmaceuticals
JAYLAXMI NALAWADE, Associate Director – Pharmacovigilance and REMS, Lupin
RICHARD WOLF, Executive Director, Pv Operations, CSL Behring
PHIL TREGUNNO, Group Manager – Vigilance, Intelligence and Research Group, MHRA (UK)
TOYIN ADEWOLE, Associate Director, Drug Safety – Clinical Research, Supernus Pharmaceuticals
SHEETAL KHEDAR, Senior Director, Regulatory Science, Sarah Cannon Development Innovations
DAVID HUTCHINSON, Founder, Brookwood International Academy
MELVA COVINGTON, Senior Principal, AGAPE Strategic Solutions
BEN LOCWIN, Senior Vice President, Quality, Lumicell

WHO SHOULD ATTEND:
CEO’s, CTO’s, CIO’s, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:
Pharmacovigilance, Pharmacoepidemiology, Pharmacogenomics, Drug/Product Safety, Drug Development, Information and Clinical Data Management, Clinical Pharmacology, Clinical Safety, Periodical safety update Reports, Risk Management, Research & Development, Quality Assurance, Patient Safety, Signal Detection, Safety Surveillance, Outcomes Research, Data Analysis, Epidemiology, Medical Affairs, Regulatory Affairs and Compliance, Information technology, Sales and Marketing
CONFERENCE SPONSORSHIP:
E-mail – kavitha@virtueinsight.co.in or Tel: +44 2036120886
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available.
We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.
CONFERENCE REGISTERATION:
In order to register contact us on Email: kavitha@virtueinsight.co.in Tel: +44 2036120886
Conference Only:

Introductory Offer (3 delegate places for the price of 2) A huge saving (Limited seats left)
Early Discount (25th June 2019 – 19th August 2019): (£1299 per delegate)
Standard Registration (20th August 2019 Onwards): (£1499 per delegate)

Conference + Workshop:

Introductory Offer (3 delegate places for the price of 2) A huge saving – (Limited seats left)
Early Discount (25th June 2019 – 19th August 201): (£1499 per delegate)
Standard Registration (20th August 2019 Onwards): (£1699 per delegate)

Workshop Oniy – £399
Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins. Expand your knowledge of the latest business models and strategies in the high-level conference.

The Marketing Disruption Summit USA
2019-10-02 - 2019-10-03 | Sheraton Philadelphia Society Hill Hotel
Harness data & tech to engage customers and dominate markets
As consumer attitudes shift to “one-click” pharma needs to shift with it.
Improving customer engagement strategies and processes are the key to improving reputations and delivering value. But how do we get there?
The answer, we can’t do it alone. The responsibility to deliver an excellent customer engagement strategy sits across several functions, at eyeforpharma Marketing Disruption Summit USA we’ll be going beyond the theoretical and bringing together all stakeholders to deliver a blueprint to revitalize customer relationships.
2019 Expert speakers include:

Anish Shindore, Head of Digital Acceleration, Sanofi
Martina Flammer, SVP, Customer Value, Boehringer Ingelheim
Judith Lyster, Digital/IT Leader Canada, Eli Lilly & Co.
Matt Smith, Global Lead, Strategy, Digital & Operations, Pfizer
Chad Dau, Head of Business and Market Analytics, Astellas
Ramon Vega, Director, Global Pharma Marketing IT, Merck

Over 200 attendees from across both front-end and back-end: Marketers, IT/technology, transformation agents, Data, Field Operations and more…will discuss how to unify efforts and develop strategy and process that performs in the field.
With the latest case studies from Sanofi, Pfizer and Ouchie, panels led by pharma leaders and out of industry expert sessions that will help you create the ultimate, effortless customer engagement strategy– this is the event to ensure your business is ready to dominate the market.

SMi’s 10th Annual Biosimilars Conference
2019-09-25 - 2019-09-26 | Copthorne Tara Hotel, London, UK, United Kingdom
Conference: Wednesday 25 and Thursday 26 September 2019
Workshop: Tuesday 24th September 2019
Chaired by Michel Mikhail, International Expert Regulatory Affairs, Global Expert Biosimilars
Discussing future regulatory, commercial and legal challenges of biosimilars
SMi Group are delighted to announce the 10th annual Biosimilars Conference taking place on 25th and 26th September 2019. This year’s event will be our first global event taking place in London, UK. The event’s focus is to highlight the current challenges in the biosimilars market and discuss current undergoing plans or developments to overcome these challenges.
The biosimilars market is forecasted to reach USD$23.6B by 2023 at a compound annual growth rate (CAGR) of 31.70%. Factors driving the increase of this market include growing demand for biosimilar drugs due to their cost-effectiveness, growing incidence of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities.
With the expiry dates of major patents fast approaching, the emerging gap in the market for biosimilars is now a major attraction for manufacturers. As the availability of biosimilars could potentially reduce direct spending by USD$54B by 2026, the question is what can current biosimilar producing companies do to join this market to benefit the patients, physicians and investors?
BENEFITS OF ATTENDING

HEAR about current strategies under development to overcome challenges with patents currently faced by many biosimilar developers
DISCUSS the possible changes in regulatory approval of biosimilars in the UK post Brexit, and how this will impact market entry
EXPLORE the latest methods in use to maintain the relationship between stakeholders, doctors and patients, with the influence of governing bodies
REVIEW FDA regulations for the approval of Biosimilars and the latest approvals

PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS
Tuesday 24th September 2019, Copthorne Tara Hotel, Central London, UK
A: US-FDA Interchangeability Guideline
08.30 – 12.30
Workshop Leader: Michel Mikhail, International Expert Regulatory Affairs, Global Expert of Biosimilars
B: Global Development of Biosimilars – what can the US learn from Europe’s Strategies to promote biosimilar uptake
13:30 – 17:30
Workshop Leader: Rodeina Challand, General Manager, Challand Biosimilar Consulting
WHO SHOULD ATTEND?
Presidents, Vice Presidents, Managing Directors, Directors, Associate Directors, Chiefs, Heads, Principals, Managers and Analysts of:

Biosimilar Development
Product Development
Commercialization
Market Access
Medical Affairs
Intellectual Property
Bioloigcs
Biopharmaceuticals
Research and Development
Generics
Biobetters
Business Development
Strategic Marketing
Drug Development
Clinical Trials
Immunogenicity Studies

Global Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK, Europe and USA.
EARLY BIRD-RATES

BOOK BY 30TH APRIL AND SAVE £400
BOOK BY 31ST MAY AND SAVE £300
BOOK BY 28TH JUNE AND SAVE £200

Biobanking 2019
2019-09-25 - 2019-09-26 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
With the estimated revenues of the global biobanking industry reaching US$ 27.54 billion in 2020, backed by an explosive CAGR of 9.5% between now and 2026. This market growth is fuelled by the increasing drive towards precision and personalised medicine and thus, quality biosamples are now in soaring demand.

Come join us in September 2019 and; thoroughly understand the latest developments in the biobanking industry; network with the industry experts and key opinion leaders; gain insight into how the biobanking industry at the forefront at driving precision medicine and enhancing research and discover ‘Drone4Care’, how drone delivery of biosamples can be a reality.
The event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications. We will cover the most relevant hot topics including: the latest biorepository technological breakthroughs, the best practices in biobanking, shifts in the biosample regulation landscape, the international biobank societies with ESBB and ISBER, along with a whole host of successful biobanking business model structures to help reinvigorate your biobank.
Benefits of attending:

Discover ‘Drone4care’ from Laurent Dollé, the innovative and daring plan to use drones for the delivery of biomaterial. Additionally, he will be detailing the new promising technology of Tissue Microarray, a bioprocessing technology that can reduced the number of needed biosamples for research from 200 down to 1

Hear from UK Biobank on the continual impact of GDPR on the biobanking landscape

Learn about a diverse range of the most successful biobanking business models from real case studies

Gain insight from the global biobank collaboration societies of ESBB and ISBER, see how you can place your biobank on the international stage

View the full agenda online:
Early bird rates:

BOOK BY 30TH APRIL AND SAVE £400
BOOK BY 31ST MAY AND SAVE £300
BOOK BY THE 28TH JUNE AND SAVE £200

Plus, two interactive half day pre-conference workshops:
Workshop A: Enhance your biobank’s commercial prowess through the application of financial and economic tools along with how to improve your biosamples data quality
Workshop Leader: Laurent Dollé, Managing Director, BWB (Biothèque Wallonie Bruxelles)
8.30 – 12.30
Workshop B: The Organic Development of a Sustainable Academic Biobank
Workshop Leader: Mary-Beth Joshi, Director, Biobank & translational Research Core, Duke University Medical Centre
1.30 – 5.30
Follow us: @SMiPharm #smibiobanking
To learn more and to register online, visit www.biobanking-event.com/Pharmajwl

Asia Skin Microbiome 2.0 Congress
2019-09-24 - 2019-09-25 | Singapore – Hotel Fort Canning
This 2-day congress includes both scientific and commercial interests with topics ranging from host-microbe interaction, skin disease, emerging technologies, interventional and cosmetic advancements, and regulatory considerations. It features new and exciting case studies, presentations and expert-led panel discussions and an exhibition of solution providers showcasing products, and ample networking opportunities.
Specific focus areas include:

Skin health, wellbeing, and microbiome-associated skin disease
Skin immunology / Microbe-host interaction
Microbe-based therapies
Emerging technologies for skin microbiome research and innovation
Cosmetic vs Therapeutic regulatory considerations
Case studies / Academic-Commercial partnerships

10% OFF – code : sk/smca/10 expire on 26th Aug 2019. Contact : saffuan@global-engage.com for group booking

Microbiome Consumer Nutrition Congress
2019-09-24 - 2019-09-25 | Hotel Kabuki – 1625 Post St, San Francisco, California, United States, 94115
The Human Microbiome is a hot bed for scientific innovation and represents a rapidly growing area of focus for nutritional companies. Rising consumer consciousness around personal healthcare and diet, coupled with substantial improvements in R&D is fuelling a new wave of products that promote human gut health and wellbeing. The global probiotics market is expected to be worth $64 Bn by 2024, an increase of $20bn from 2017.
The Microbiome Consumer Nutrition Congress connects the dots between business, scientific innovation, regulation and product development in the converging fields of functional foods, pre/probiotics and the gut microbiome.
Top 10 reasons to attend:

Connect with and understand what leading nutrition, consumer health and CPG companies look for when forming strategic partnerships.
Understand the key branding and business features that VCs and Investors look for when investing in the next wave of gut health products, and how to build an effective investment deck to support your company’s next round of fundraising.
Discover the key ingredients leading health and wellness retailers seek for the next best-selling pre/probiotic products.
Discover the latest advancements in personalized microbiome diagnostics and how these can be translated into nutrition programs and products.
Understand the key business opportunities in the microbiome consumer nutrition space and how to capitalize on them.
Expand your understanding of the modern health and wellness consumer, the language they understand and what they’ll buy.
Apply the key take-aways from world leading microbiome consumer nutrition companies who have successfully branded and marketed their products and grown their businesses.
Discover the latest and most innovative scientific microbiome developments and how these can be utilized to develop the next generation of commercially successful consumer products.
Develop your understanding of regulatory considerations for microbiome-based products to improve the quality of your product’s claims and overcome regulation challenges.
Understand the timing and cost realities of bringing a gut probiotic to market and utilize this knowledge to efficiently release your next product.

The Skin Microbiome Congress Westcoast
2019-09-24 - 2019-09-25 | Hotel Kabuki, 1625 Post St, San Francisco, CA, 94115, United States
The microbiome is set to be one of 2019’s biggest skincare trends, therefore we are incredibly excited to bring The Skin Microbiome Congress back to San Francisco for the 6th event in our global series.

Last year, we connected 600+ industry leaders from pharma, beauty and personal care multinational brands with innovative independent skincare brands, bio-techs, researchers and academics who are advancing the skincare industry. This year, we continue to focus on developing a functional understanding of the skin microbiome, keeping up with the latest scientific research and competitive intelligence, as well as focusing on ‘the business of skin microbiome’ – commercializing the trend.
WHAT MAKES 2019 DIFFERENT?
New topics including skin microbiome based-products, skin conditions, personalization, skin-gut supplements, anti-ageing and commercializing ethically marketed and clinically proven products; as well as presenting the latest academic research – more researchers than ever will be showcasing the latest developments from top universities.
Also new for 2019, we are co-locating with our Microbiome Consumer Nutrition Congress – tailor your agenda and learn about the relationship of skin/gut microbiome and supplements.
Our 2018 event SOLD OUT, so make sure you don’t miss out! Download our agenda now.
To learn more about The Skin Microbiome Congress WestCoast, and to register online, visit https://go.kisacoresearch.com/l/678123/2019-05-30/5hp8
Contact:
Phone: +44 (0)203 897 6822
Email: mh@kisacoresearch.com

2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019
2019-09-19 | Kohinoor Continental Hotel, Mumbai, India, Mumbai, India
2nd Annual Pharma Packaging, Labelling, Serialisation,
Track and Trace 2019
“Securing your Supply Chain and Quality Management”
19th September 2019, Kohinoor Continental Hotel, Mumbai, India
2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019 overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems, this conference addresses serialisation; track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products. Please contact me on KAVITHA at Email: kavitha@virtueinsight.co.in or Call: +91 9940791115.
CONFERENCE DELEGATE REGISTRATION:
In order to register contact us on E-mail – kavitha@virtueinsight.co.in Tel: +91 44 24762472 OR M: +91 9940791115
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.

Early Bird Discount Price (Valid until 06th August) – 1 Delegate – (INR 10,000 + GST (18%) per delegate)
Standard Price (Valid From 07th August) – 1 Delegate – (INR 15,000 + GST (18%) per delegate)
For Bulk Booking of More Than 5 Delegates – Please let us know your interests.

CONFERENCE SPONSORSHIP:
E-mail – kavitha@virtueinsight.co.in in Tel: +91 44 24762472 Or M: +91 9940791115
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available.
We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

Introducing the First list of confirmed Speakers

K. BANGARURAJAN, Joint Drugs Controller (INDIA), CDSCO (HQ)
RUBINA BOSE, Deputy Drugs Controller(India), CDSCO (WZ)
MAYUR PARMAR , Deputy Collector, Government Of Gujarat
SUDHIR MOHAN BANSAL, Vice President & India Head of Supply Chain Management, Pfizer
AMIT KALE, Associate Vice President – Packaging and Automation, Reliance
OMPRAKASH S. SADHWANI, Former Joint Commissioner and controlling Authority Food and Drug Administration (Maharashtra state)
CHANDRA SEKHAR, Vice President Quality, Reliance Life Sciences
UDAYKUMAR RAKIBE, Founder, PharmaMantra
VAIBHAV KULKARNI, Director – Regulatory Affairs, Abbott Nutrition
NARESH TONDARE, Senior Director – National Regulatory Affairs, Biocon
SUNIL ACHARYA , Packaging Development, S.C.P.L
RITESH GOHEL, Lead, Global Serialisation and Track & Trace, Sun Pharma
S.R.SALUNKHE, Former Assistant commissioner – FDA Maharashtra
PRABIR DAS, Head – Packaging Tech Services, OSD, Mylan Laboratories
SANJAY KUMAR, Head Of Legal, Emcure Pharmaceuticals
SANJAY DAVE, CCO, Anfarnd Consultancy Services
VISHWAS SOVANI, Founder Director, Pharmawisdom
GAURAJ SHAH, Counsel, Bombay High Court
VIRENDRA SINGH, Senior Manager, Reliance Life Sciences
JAGDISH VYAS, Manager, Abbott
RAJSHRI CHETAN PARDESHI, Manager – New Product & Commercial Packaging Development, and Sourcing Head for Regulated Market, Unosource Pharma (An Akums Enterprise)
DARSHAN VARTAK , Head Packaging Technical, Anchor by Panasonic

Plus many more
WHO SHOULD ATTEND:
CEO’s, CTO’s, CIO’s, Presidents, Vice Presidents, Directors Heads & Managers of:
Pharmaceutical manufacturers and distributors, Healthcare professionals, Pharmacists, Serialisation, Track and Trace – Solution providers, Brand – protection, enforcement, security, integrity and management companies, Drug regulatory agencies, customs and police, Intergovernmental organizations (IGOs) involved in healthcare and IPR protection, Non-governmental organizations (NGOs) active in healthcare, Patients’ representatives, Healthcare research organizations, Pharmaceutical associations, Anti-counterfeiting organizations, Packaging, labeling and converting companies, Authentication technology suppliers, Anti-counterfeiting service suppliers – IP specialists, investigators, lawyers.
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

2nd Annual AI-ML Clinical Development Summit
2019-09-18 - 2019-09-19 | Aloft Boston Seaport District 401-403 D Street, Boston, MA, 02210, United States
Optimize When & How to Practically Apply AI & Machine Learning to Improve the Efficiency, Patient Recruitment, Design and Outcomes of Clinical Trials
Designed with leading AI and R&D experts from the likes of GSK, Pfizer, Takeda, Celgene, AbbVie and academic KOLs, & containing real world use cases of AI in action, this year’s AI-ML: Clinical Development Summit tackles both the critical scientific and technical challenges, as well as identifying opportunities, of implementing AI and machine learning (ML) to optimize your clinical development.
This is a critical time for drug developers to make more data-driven decisions that lead to improved efficacy, safety and approval outcomes. Only here you will learn when, strategically, it is the right time to invest and apply AI to transform your clinical trial success.
As clinical failure rates remain unsustainable and the vast amounts of patient data increases further, AI, data and clinical development and pharmacovigilance experts from across large pharma and biotech are gathering to discover the growing practical applications of AI and ML.
With 60+ thought-leaders converging at the AI-ML Clinical Development Summit, this will surely be an unrivalled opportunity for you to learn first-hand the growing practical applications of AI and ML.

Discover how to technically integrate and apply AI algorithms to enhance trial design, improve patient selection and retention and achieve more precise pharmacovigilance studies.
Grasp how AI will fundamentally change the paradigm of clinical trial execution and identify key areas where AI can positively impact your drug development decision making.
Harness AI and extract maximum value to achieve regulatory success and accelerate novel therapeutic products to market.

To learn more and to register online, visit: https://ai-clinicaldevelopment.com/

7th Annual IMPACCT: RWE
2019-09-18 - 2019-09-19 | Aloft Boston Seaport District 401-403 D Street, Boston, MA, 02210, United States
Returning for its 7th year, IMPACCT: RWE provides top innovators and leaders in the real world evidence space with a comprehensive industry forum dedicated to supporting and advancing the generation and utilization of real world evidence across drug life cycle, from clinical development to commercialization.
Join your peers and leading experts for a collaborative open discussion aiming to tackle key challenges to accelerate the meaningful implementation of real world evidence approaches to enhance clinical R&D outcomes, drive patient-centricity, and maximize the success of launch and commercialization activities.
Real world evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real world into their development programs, drug developers are now able to drive more patient-facing outcomes, by supporting it with effective evidence-based decision-making across the product life cycle.
At a point of increasing maturity, regulatory acceptance, and growing innovation, these are exciting times for all stakeholders actively involved in the efforts to advance the effective utilization and generation of real world evidence.
Leading experts in the space will be tackling questions and sharing the latest case-studies around the use of RWE in:

Patient identification
Clinical trial design
Historic control arms
Outcomes research
Observational research
Post-launch safety studies
Defining medical affairs strategy
Value generation across the product life cycle
Regulatory decision-making
Label extensions
Patient access

… and more.
Join them at this collaborative discussion platform that aims to bring together stakeholders from functions across clinical development, HEOR, regulatory and medical affairs, epidemiology and RWE, to overcome key challenges to define and implement a meaningful evidence generation plan that can effectively enhance clinical R&D, support regulatory submission and decision-making, and ultimately drive commercial success.
To learn more and to register online, visit: https://impacct-rwe.com/

13th Digital Pharma East
2019-09-17 - 2019-09-20 | Pennsylvania Convention Center
The 13th Digital Pharma East, http://bit.ly/307A0WT, returns to the Pennsylvania Convention Center, September 17-20. Discover how you can present business plans, justify budget, innovation and de-risk proposals when you join us for this annual event. Register with Discount Code DPE19PJ to secure your seat, http://bit.ly/2xsmS2a.
Make sure to download the brochure to see what’s on the agenda: http://bit.ly/2Jak8gN

Inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit
2019-09-17 - 2019-09-18 | Hilton Singapore, 581 Orchard Rd, 238883, Singapore
Inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit
Advance the Next Generation of Safe, Effective & Commercially Viable Microbiome-Based Therapeutics & Nutritional Products
17-18 September 2019 | Singapore
Website: https://ter.li/tf7voy

Part of the globally recognised Microbiome Movement, we are delighted to announce the arrival of the inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit to help translational microbiome researchers in APAC discover, develop and deliver the future generation of microbiome-based products across therapeutic and nutritional industry applications.
This year’s forum will play an important role in reviewing the major scientific and commercial progress areas in microbiome research in APAC but also help you stimulate new business opportunities in a new and exciting field. Join and interact with industry and academic key opinion leaders from Asia’s prominent microbiome-focused organisations at this year’s forum to accelerate your knowledge of the field, overcome key challenges in translating your microbiome research to commercial reality and help deliver a new future for healthcare.
Early booking and group discounts are available. Visit the website to learn more: https://ter.li/tf7voy

TIDES: Oligonucleotide & Peptide Therapeutics Digital Week
2019-09-16 - 2019-09-19 | MA
4-day complimentary series of live educational webcasts and downloadable resources uncovering insights to accelerate oligonucleotide and peptide products from early discovery to commercialization.

Why Attend A Webinar?

Time and Cost Efficient
You will save valuable time and money because there is no need to travel and no registration fee.
Focused and Timely Learning
You will receive the latest “hot” and timely data from a leading authority
Convenience
You can participate in a webinar from a location of your choosing – your home, your office, or a client/customer location

Sign up now: www.TIDESDigitalWeek.com

5th Annual CAR-TCR Summit
2019-09-10 - 2019-09-13 | Seaport Hotel & World Trade Center, One Seaport Lane, Boston, MA, 02210, United States
The definitive, world-renowned summit dedicated to providing comprehensive insight into the full end-to-end pharmaceutical value chain for CAR-TCR therapies in liquid and solid tumor indications.
The CAR-TCR Summit remains at the forefront of the industry bringing you never-seen-before data from the movers and shakers in CAR and TCR therapy development.

Dedicated to discussing the next generation candidates beyond CD19, from solid tumor indications to autoimmune disorders, this meeting provides an in depth breakdown of the current strategies to optimize the durability, persistence and targeting of approved and novel therapies to reduce relapse rates and overcome toxicity.
At the premier, end-to-end summit focused on early research through to commercialization, join the experts to discuss how to streamline process development and logistics supply chains for affordable and accessible CAR-TCR therapeutics.
Take advantage of the unrivalled networking opportunities as we bring together over 1000 industry leaders developing CAR-TCR based therapies from across pharma, biotech, regulatory bodies, academia, solution and service providers.
Here’s a snapshot of the 140+ world class speaker faculty:

James Noble, Chief Executive Officer, Adaptimmune
Barbra Sasu, Chief Scientific Officer, Allogene
Chris Haqq, Chief Scientific Officer, Atara Biotherapeutics
Elsy Boglioli, Chief Operating Officer, Cellectis
Jean-Pierre Latere, Chief Operations Officer, Celyad
Katherine Szarama, Evidence Development Division, Coverage & Analysis Group, Center for Clinical Standards and Quality, Centers for Medicare & Medicaid Services
Cheng Liu, Chief Executive Officer, Eureka Inc.
Jason Krentz, Chief Technology Officer, Tmunity Therapeutics
Thomas Andresen, Chief Scientific Officer, Torque Therapeutics
Matthew Spear, Chief Medical Officer, Poseida Therapeutics

Download the event guide for the full details of the speaker line-up, agenda and discounts available.

Pharma and Device Packaging and Labelling Europe 2019
2019-09-10 - 2019-09-11 | Munich, Germany
After a successful European launch, a special thank you to all our attendees at the Pharma Packaging and Labelling Conference! Arena International is delighted to announce we will be returning to Munich in 2019 for another superb year.
We have welcomed more than 100 attendees from across the region for two days of engaging presentations from the biggest names in the sector.
The 2018 programme looked at ongoing regulations, ensuring patient safety and making sure the right systems are in place which is more crucial than ever with the ever looming FMD regulations. Top pharmaceutical companies, biotechs, CMOs and medical device companies such as Abbott, Sandoz, Coloplast, AbbVie, Novartis, Roche; including regulatory bodies GS1, EAASM and many more came together to share their insights into compliant packaging and labelling implementation.
Pharma Packaging and Labelling Europe will be returning in September 2019. We look forward to seeing you all there!

3D Tissue Models Summit
2019-09-04 - 2019-09-06 | Hilton Boston Back Bay 40 Dalton St Boston, MA 02115, USA
The 3D Tissue Models Summit will bring together 120+ industry stakeholders across the regulatory, pharma, biotech and academic landscapes to discuss the latest insight into established validation techniques to increase reproducibility and improve the preclinical effectiveness of drug candidates.
Join us and discover:
20+ latest case studies showcasing the advantages of high throughput screening techniques across the 3D model continuum to drive drug discovery progress.
FDA guidance into the regulatory landscape to define a common language of key terms across the industry for end users.
NIH and IQ Consortia discussing the latest developments to incorporate platform-specific standardization and reproducibility metrics for organoids and tissue chip technology.
Model developers and academic experts revealing how to overcome translational challenges to define disease-relevant endpoints across a variety of model types.
Take advantage of this unrivalled learning and networking opportunity packed with content and dedicated interactive formats to ensure you leave equipped with the connections and takeaways to enhance the predictive success of your preclinical 3D models.

2nd Microbiome Movement - Skin Health & Dermatology Summit
2019-09-04 - 2019-09-06 | The Westin San Diego, 400 West Broadway, San Diego, CA, 92101, United States
2nd Microbiome Movement – Skin Health & Dermatology Summit
Translate the Skin Microbiome into Safe, Effective & Commercially Viable Dermatological Therapeutics & Cosmetic Products
4-6 September 2019 | San Diego
Website: https://ter.li/bsl3rt
As scientific researchers continue to investigate the complexities of the skin microbiome, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple: Build a collaborative forum that unites forward thinking academic, dermatological & cosmetic researchers, and lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing solutions that modify the skin microbiome to treat disease (therapeutics) or support overall skin health (cosmetics).

Our conversations have highlighted that although a strong commercial opportunity exists, there are critical areas of basic science that need addressing including study design to elucidate host-microbiome interactions, selecting the right tools to make clear correlations between microbial dysbiosis and skin disease and standardization of sample collection and analysis.
If you’re keen to make sense of skin microbiome science and its application to the therapeutic and cosmetic industry, join over 100+ scientifically-driven researchers from academia, biopharma and the cosmetic community to help you discover, translate and commercialize breakthrough therapeutics or cosmetics that improve skin health.
Early booking and group discounts are available. Visit the website to learn more: https://ter.li/bsl3rt

3rd Annual IPF Summit
2019-08-27 - 2019-08-29 | Sheraton San Diego Hotel & Marina, 1380 Harbor Island Drive, San Diego, CA, 92101, United States
The IPF Summit focuses exclusively on closing the translational gap between preclinical predictability and clinical attrition to accelerate the development of truly curative idiopathic pulmonary fibrosis (IPF) therapeutics.

With the 2019 conference expanding upon an even greater breadth and depth of content, you’ll hear three days of unrivalled scientifically driven and case-study based analysis and discussion, as together leading academia and biopharma advance the IPF drug development frontier.
Last year, over 90 of IPF’s expert drug developers came together to advance the standardisation of imaging, share clinical insights, and evaluate better recapitulating disease physiology in vitro exclusively for IPF:
“This was a superb meeting combining several emerging themes in IPF therapies and a dynamic mix of formal presentations with impromptu networking. All the speakers were excellent, and every session provided novel and important insight regarding IPF. The effort the speakers put into their presentations was evident. Great job!”
Ceders-Sinai Medical Center
With the incredible breakthrough success of drugs now in our arsenal for slowing IPF disease progression, the increasing importance of identifying genetic mechanisms, closing the translational gap between preclinical and clinical results, and developing candidates to reverse fibrosis have opened up further challenges within IPF drug development.
Join “part 3” as the IPF community converges again to:

Analyze the latest understanding of IPF pathology for improved target validation of next generation therapeutics and the potential to promote tissue regeneration to achieve reversal of fibrosis
Critically discuss how to design the next generation of phase III clinical trials for candidate success in light of a current standard of care
Outline progressions in the standardization of imaging and advancements of biomarkers to improve translational success and more confident diagnosis of patients

To learn more about 3rd Annual IPF Summit and to register online, visit https://ter.li/i81anp
Contact
Email – info@hansonwade.com
Phone – +1 415 735 3289

4th Annual Medical Device Regulatory and Quality Summit 2019
2019-08-22 - 2019-08-23 | New Delhi, India
4th Annual Medical Device Regulatory and Quality Summit 2019 will create a platform for regulators, industry stalwarts to come under one roof to discuss and share ideas that would not only benefit their organisations, but at large the industry as well. The 4th Annual Medical Device Regulatory and Quality Summit 2019 will review the evolving regulations, their impact on the industry as well as take an in depth look into areas of quality control and assurance.

To learn more about this event, and to register online, visit http://bit.ly/2MgH15z

2nd Annual Hemophilia Drug Development Summit
2019-08-20 - 2019-08-22 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
Given the excitement and anticipation of increasingly more promising prophylactic treatments and gene therapies, the 2nd Annual Hemophilia Drug Development Summit, once again unites leading pharma, biotech and academic KOLs working to translate and clinically develop longer acting and more efficacious therapies to overcome significant unmet medical need and hemophilia and other bleeding disorders.

Attend the 2nd Hemophilia Drug Development Summit to identify novel drug development strategies and overcome the shared translational, clinical development and delivery challenges to dramatically improve patient outcomes.
Sounds interesting? Find out more – get free event brochure here: https://ter.li/4snxn9
